EP2477601A2 - Compositions de soin personnel avec des dispersions aqueuses de copolymère éthylène-acide acrylique - Google Patents

Compositions de soin personnel avec des dispersions aqueuses de copolymère éthylène-acide acrylique

Info

Publication number
EP2477601A2
EP2477601A2 EP10755297A EP10755297A EP2477601A2 EP 2477601 A2 EP2477601 A2 EP 2477601A2 EP 10755297 A EP10755297 A EP 10755297A EP 10755297 A EP10755297 A EP 10755297A EP 2477601 A2 EP2477601 A2 EP 2477601A2
Authority
EP
European Patent Office
Prior art keywords
personal care
care composition
hair
ethylene
aqueous dispersion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP10755297A
Other languages
German (de)
English (en)
Other versions
EP2477601B1 (fr
Inventor
Susan Jordan
Tatiana Drovetskaya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Union Carbide Chemicals and Plastics Technology LLC
Original Assignee
Union Carbide Chemicals and Plastics Technology LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union Carbide Chemicals and Plastics Technology LLC filed Critical Union Carbide Chemicals and Plastics Technology LLC
Publication of EP2477601A2 publication Critical patent/EP2477601A2/fr
Application granted granted Critical
Publication of EP2477601B1 publication Critical patent/EP2477601B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/12Preparations containing hair conditioners
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair

Definitions

  • the present application relates to personal care compositions.
  • Conditioning of hair and/or skin is one of the most desired attributes in a personal care composition, particularly conditioners, shampoos, and body washes.
  • Cationic polymers are known to provide conditioning benefits, but can tend to build up on hair and cause limp and/or unmanageable hair.
  • Other conditioning agents containing oily (silicone) or waxy (fatty acids) material are known, but have several drawbacks, including the proclivity of silicones to wash off the hair when paired with surfactants.
  • a conditioning shampoo that can clean, condition, and increase manageability, for example, exhibit improved curl retention and frizz control (that is, a reduction in the appearance or intensity of frizz, a term of art referring to an aesthetically undesirable appearance of individual hair fibers behaving independently and non-uniformly, whether from static, humidity, or damage).
  • the present invention provides personal care compositions, comprising an aqueous dispersion comprising an ethylene acrylic acid copolymer and a least one cosmetically acceptable surfactant, emollient, or cosmetic active.
  • the present invention provides personal care compositions, comprising an aqueous dispersion comprising an ethylene acrylic acid copolymer and a least one cosmetically acceptable surfactant, emollient, or cosmetic active.
  • Personal care relates to compositions to be topically applied to a person (including mouth, ear, and nasal cavities, but not ingested).
  • personal care compositions include skin care products (e.g., facial cream, moisturizers, leave on and rinse off lotions, sunscreens, foundation, mascara, eye-liner, lipstick, cleansers, and the like) and hair care products (including shampoos, leave on and rinse off conditioners, styling gels and hairsprays).
  • the personal care composition is a shampoo, a rinse-off conditioner, a leave-in conditioner, or a body wash.
  • the personal care composition is not an emulsion.
  • Cosmetically acceptable refers to ingredients typically used in personal care compositions, and is intended to underscore that materials that are toxic when present in the amounts typically found in personal care compositions are not contemplated as part of the present invention.
  • ethylene-acrylic acid (EAA) copolymers which are known as flexible thermoplastics for blister packaging and the like.
  • a preferred ethylene acrylic acid copolymer comprises greater than about 15 wt% acrylic acid, preferably greater than about 17 wt% acrylic acid, more preferably about 20 wt% acrylic acid. It should be understood that ranges recited in this disclosure include all
  • a preferred EAA copolymer is PRIMACOR 5990 copolymer (20 wt% acrylic acid), which has a melt index of 1300 g/10 minute (ASTM Method D-1238 at 190° C) and a Brookfield viscosity of 13,000 cps at 350° F, and is available from The Dow Chemical Company.
  • Another preferred EAA copolymer is PRIMACOR 5980i copolymer (20.5 wt% acrylic acid), which has a melt index of 300 g/10 minute (ASTM Method D-1238 at 190° C), available from The Dow Chemical Company.
  • EAA copolymers are also available under the tradename NUCREL 2806, available from E.I. du Pont de Nemours and Company, Inc.
  • Ethylene-acrylic acid and ethylene-methacrylic acid copolymers are described in U.S. Pat. Nos. 4,599,392, 4,988,781, and 5,938,437, each of which is incorporated herein by reference in its entirety.
  • the solids content of the aqueous dispersion is in a range from about 10% by weight to about 30% by weight, preferably about 20% by weight.
  • the aqueous dispersion is present in a range from about 0.05 wt% to about 10 wt% of solids, preferably about 0.25 wt% to about 5 wt%, by weight of the personal care composition.
  • the ethylene acrylic acid copolymer is present in a range from about 15 wt% to about 60 wt% of solids by weight of the aqueous dispersion.
  • the aqueous dispersion comprising an ethylene acrylic acid copolymer can include additional components, for example, at least one anti-dandruff active (zinc pyrithione, salicylic acid, or selenium compounds), sunscreen actives (organic or inorganic), pigment, fragrance, botanical, amino acid, or vitamin.
  • the aqueous dispersion comprises an ethylene acrylic acid copolymer and a metallocene catalyzed polyolefin.
  • the ethylene acrylic acid copolymer and metallocene catalyzed polyolefin is in a polymer ratio of about 40:60 to about 15:85.
  • the solids content of the aqueous dispersion is in a range from about 30% by weight to about 50% by weight, preferably about 40% by weight.
  • the ethylene acrylic acid copolymer is present in a range from about 15 wt% to about 60 wt% of the solids by weight of the aqueous dispersion, preferably in a range from about 35 wt% to about 45 wt% of the solids. This correlates to ethylene acrylic acid copolymer being present in a range from about lwt% to about 25 wt% by weight of the aqueous dispersion, preferably in a range from about 5 wt% to about 20 wt%.
  • Metallocene catalyzed polyolefins are polyolefins produced with a metallocene catalyst as described in U.S. Pat. Nos. 4,701,432, 5,322,728, and 5,272,236, each of which is incorporated herein by reference in its entirety.
  • the metallocene catalyzed polyolefins are polyethylenes produced with a metallocene catalyst.
  • Such metallocene catalyzed polyethylenes are available e.g. from The Dow Chemical Company under the trademark AFFINITY or ENGAGE (ethylene/octene copolymers) and from Exxon Chemical Company under the trademark EXACT
  • the metallocene catalyzed polyolefin is at least one of ethylene/octene copolymers, ethylene/butene copolymers, ethylene/hexene copolymers, ethylene/propylene or ethylene/butene/hexene terpolymers, preferably an ethylene octene copolymer.
  • the metallocene catalyzed polyolefin is a
  • propylene/alpha-olefin copolymer which is further described in details in the U.S. Patent Nos. 6,960,635 and 6,525,157, each of which is incorporated herein by reference in its entirety.
  • Such propylene/alpha-olefin copolymers are commercially available from The Dow Chemical Company, under the tradename VERSIFYTM, or from ExxonMobil Chemical Company, under the tradename VISTAMAXXTM.
  • the ethylene acrylic acid copolymer and metallocene catalyzed polyolefin are melt-kneaded in an extruder along with water and a neutralizing agent, such as ammonia, potassium hydroxide, or a combination of the two, to form an aqueous dispersion.
  • a neutralizing agent such as ammonia, potassium hydroxide, or a combination of the two
  • the present invention provides personal care compositions, comprising an aqueous dispersion comprising an ethylene acrylic acid copolymer, optionally, metallocene catalyzed polyolefin, and a silicone, provided that the silicone is not in the aqueous dispersion.
  • Silicones include silicone oils, for instance volatile or non-volatile polymethylsiloxanes (PDMS) comprising a linear or cyclic silicone chain, which are liquid or pasty at room temperature, especially cyclopolydimethylsiloxanes (cyclomethicones) such as cyclopentasiloxane and cyclohexadimethylsiloxane, polydimethylsiloxanes comprising alkyl, alkoxy or phenyl groups, which are pendent or at the end of a silicone chain, these groups comprising from 2 to 24 carbon atoms, phenyl silicones, for instance phenyl trimethicones, phenyl dimethicones, phenyltrimethylsiloxydiphenylsiloxanes, diphenyl dimethicones, diphenylmethyldiphenyltrisiloxanes 2-phenylethyltrimethyl siloxysilicates and
  • polymethylphenylsiloxanes fluoro oils such as partially hydrocarbon-based and/or partially silicone-based fluoro oils, preferably dimethicone, cyclopentasiloxane, cyclohexasiloxane, or a combination thereof.
  • fluoro oils such as partially hydrocarbon-based and/or partially silicone-based fluoro oils
  • dimethicone cyclopentasiloxane
  • cyclohexasiloxane a combination thereof.
  • a preferred blend of dimethicone, Laureth-23, and C 12-15 Pareth-3 is commercially available from Dow-Corning under the tradename DOW CORNING 2-1491 Silicone Emulsion, also described as a 60% large particle size non-ionic emulsion of a blend of ultra-high molecular weight polydimethylsiloxane gum and intermediate molecular weight polydimethylsiloxane fluid.
  • the silicone is present in a range from about 0.1 wt% to about 5 wt%, preferably from about 0.75 wt% to about 3 wt%, and more preferably from about 1 wt% to about 2 wt%, by weight of the personal care composition.
  • the surfactant is a cationic, anionic, nonionic, or amphoteric surfactant, or a mixture thereof.
  • the surfactant is a nonionic/emulsifier surfactant.
  • the surfactant is a cationic surfactant, preferably behentrimonium chloride.
  • the surfactant is present in an amount from about 0.1 wt% to about 10 wt% by weight of the composition, preferably from about 0.5 wt% to about 7 wt% by weight of the composition, most preferably from about 1 wt% to about 4 wt% by weight of the composition.
  • the surfactant is a detergent surfactant.
  • the surfactant is present in an amount from about 1 wt% to about 25 wt% by weight of the composition, preferably from about 5 wt% to about 20 wt% by weight of the composition, most preferably from about 7 wt% to about 18 wt% by weight of the composition.
  • the detergent surfactant is an anionic surfactant in combination with an amphoteric surfactant.
  • the anionic surfactant is ammonium laureth sulfate, ammonium lauryl sulfate, sodium laureth sulfate, or sodium lauryl sulfate.
  • the anionic surfactant is present in an amount from about 1 wt% to about 25 wt%, preferably from about 5 wt% to about 20 wt%, more preferably from about 7 wt% to about 15 wt%, by weight of the composition.
  • the mixture is an anionic surfactant in combination with a second surfactant that is disodium cocoamphodiacetate, decylglucoside, or cocamidopropyl betaine.
  • the second surfactant is present in an amount from about 1 wt% to about 10 wt%, preferably from about 1 wt% to about 8 wt%, more preferably from about 2 wt% to about 6 wt%, by weight of the composition.
  • the surfactant is a mixture of sodium laureth sulfate (such as is commercially available from Cognis as under the tradename STAND APOL ES) and disodium cocoamphodiacetate (such as is commercially available from Henkel as under the tradename VELVETEX CDC).
  • the surfactant is a mixture of sodium laureth sulfate and disodium cocoamphodiacetate, the ratio of sodium laureth sulfate to disodium
  • cocoamphodiacetate is in a range from about 9:1 to about 2:1, most preferably about 6:1.
  • the composition includes citric acid to adjust the pH.
  • the composition further comprises a cationic polymer.
  • Cationic polymer is herein defined as a polysaccharide modified to have a positive charge, for example, cationic cellulose derivatives (including for example PQ 10, PQ 24, and PQ 67), cationic guar derivatives, cationic methacrylamido polymers, and synthetic cationic polymers, such as PQ6 and PQ7.
  • the cationic polymer is cationically modified hydroxyethylcellulose, which is commercially available from The Dow Chemical Company under the tradename UCARE.
  • Other optional ingredients for personal care compositions of the present invention include cosmetically acceptable emollients, sunscreens, surfactants, emulsifiers,
  • preservatives preservatives, rheology modifiers, colorants, dyes, preservatives, pH adjustors, propellants, reducing agents, fragrances, foaming agents, tanning agents, depilatory agents, flavors, astringents, antiseptics, deodorants, antiperspirants, insect repellants, bleaches, lighteners, anti-dandruff agents, adhesives, polishes, strengtheners, fillers, barrier materials, or biocides.
  • the personal care composition further comprises an optional rheology modifier as a thickener.
  • thickeners include polymers, for example, modified or unmodified carboxy vinyl polymers, such as the products sold under the names CARBOPOL and PEMULEN (INCI name: Acrylates/Cio-30 alkyl acrylate crosspolymer; available from Noveon), polyacrylates and polymethacrylates, such as the products sold under the names LUBRAJEL and NORGEL (commercially available from Guardian) or HISPAGEL (commercially available from Hispano Chimica), polyacrylamides, 2- acrylamido-2-methylpropanesulfonic acid polymers and polymers, which are optionally crosslinked and/or neutralized, for instance the poly(2-acrylamido-2-methylpropane-sulfonic acid) sold by Clariant (INCI name: ammonium polyacryldimethyltauramide), emulsified crosslinked anionic polymers of acrylamide and AMPS, such as those
  • Colorants include pigments, which are used especially in make-up, including metal oxide pigments, titanium dioxide, optionally surface-treated, zirconium oxide or cerium oxide, zinc oxide, iron oxide (black, yellow or red), chromium oxide, manganese violet, ultramarine blue, chromium hydrate and ferric blue, carbon black, pigments of barium, strontium, calcium or aluminum (for example D&C or FD&C), cochineal carmine, mica coated with titanium or with bismuth oxychloride, titanium mica with iron oxides, titanium mica with, especially, ferric blue or chromium oxide, titanium mica with an organic pigment, nacreous pigments based on bismuth oxychloride, goniochromatic pigments, for example pigments with a multilayer interference structure, reflective pigments, for example particles with a silver-coated glass substrate, glass substrate coated with
  • nickel/chromium/molybdenum alloy glass substrate coated with brown iron oxide, particles comprising a stack of at least two polymer layers, for instance MIRROR GLITTER
  • Dyes include water-soluble dyes such as copper sulfate, iron sulfate, water-soluble sulfopolyesters, rhodamines, natural dyes, for instance carotene and beetroot juice, methylene blue, caramel, the disodium salt of tartrazine and the disodium salt of fuschin, and mixtures thereof. Liposoluble dyes from the list above can also optionally be used.
  • Preservatives include alcohols, aldehydes, methylchloroisothiazolinone and methylisothiazolinone, p-hydroxybenzoates, and in particular methylparaben, propylparaben, glutaraldehyde and ethyl alcohol.
  • the pH adjustors include inorganic and organic acids and bases and in particular aqueous ammonia, citric acid, phosphoric acid, acetic acid, and sodium hydroxide.
  • Reducing agents include ammonium thioglycolate, hydroquinone and sodium thioglycolate.
  • Fragrances can be aldehydes, ketones, or oils obtained by extraction of natural substances or synthetically produced as described above. Often, fragrances are accompanied by auxiliary materials, such as fixatives, extenders, stabilizers and solvents.
  • Biocides include antimicrobials, bactericides, fungicides, algaecides, mildicides, disinfectants, antiseptics, and insecticides.
  • the personal care composition is a shampoo, body wash, or facial cleanser, preferably a shampoo.
  • the personal care compositions are applied to hair or skin.
  • applying the present personal care compositions constitute a method of conditioning hair.
  • the present invention comprises a shampoo that cleans, conditions, and increases manageability, for example exhibits improved curl retention and frizz control.
  • compositions of the present invention include aqueous dispersions comprising an ethylene acrylic acid copolymer.
  • aqueous dispersions include the following:
  • PRIMACOR 5980i 20% ethylene acrylic acid resin (133g), potassium hydroxide (17.2g), and water (200g) are placed in a 300 mL Parr reactor vessel fitted with a Cowles blade. The material is heated to 120°C while mixing slowly. Once the set temperature is reached, the mixer is run on high (-1800 rpm) for 25 minutes. While still mixing on high, the sample is diluted with water fed into the reactor with an HPLC pump at a rate of 40mL/min to the desired concentration of 23% solids by weight based on the amount of Primacor. Heat is removed and stirring continues until the temperature cools to at least 45°C. The Parr is then opened and the dispersion is collected.
  • PRIMACOR 5980i 20% ethylene acrylic acid resin (30.7g), potassium hydroxide (4g), and water (92g) are placed in a Parr reactor vessel fitted with a Cowles blade. The material is heated to about 120°C while mixing slowly. Once the temperature is reached, the mixer is run on high (-1800 rpm) for about 25 minutes. Heat is removed and stirring continues until the temperature cools to at least 30°C.
  • ZPT Zinc Pyrithione
  • Exemplary personal care shampoo compositions contain the components recited in TABLE 1 on a weight/weight basis (wt. %).
  • Conventional personal care shampoo compositions contain the components recited in TABLE 2 on a weight/weight basis (wt. %).
  • Control shampoos are prepared substantially as described in Example 2, but contain 0.3% of a conventional cationic conditioning polymer (i.e., JAGUAR C-13S guar, UCARE polymer JR400, UCARE polymer LR30M) instead of the aqueous dispersion.
  • a conventional cationic conditioning polymer i.e., JAGUAR C-13S guar, UCARE polymer JR400, UCARE polymer LR30M
  • compositions substantially according to the protocols of Examples 2 and 3 were prepared. Pre- washed and pre-hydrated tresses of European Virgin-Brown and 8-hour bleached hair (available from International Hair Importers and Products Inc.) were treated with 0.5 g of these shampoo formulations. The shampoo was worked into the hair for 1 min. and then rinsed off under running tap water at 38°C at 0.4 gal./min. water flow.
  • the hair tresses were hung for wet sensory evaluation study. After the tresses were completely dried, dry sensory evaluations were conducted. Ten expert panelists trained to evaluate the performance of cosmetic products on hair were asked to evaluate comb-ability and feel in both the wet and dry stage. Each panelist evaluated a pair of tresses, one tress treated with a composition of the invention versus one treated with a comparative
  • hair tresses (8 hour bleached) were washed as above using Formulation A or Comparative 3 and dried.
  • Objective dry combing measurements were taken using a DIA-STRON device from Dia-Stron Limited, Hampshie, UK. The lower force required to pull the comb through the hair, the more conditioned the hair is.
  • Formulation A shows as good or better dry combing force as Comparative 3 with air drying (2189 compared to 2220) and significantly better for blow drying (656 compared o 1621), signifying excellent conditioning even in the absence of a cationic polymer.
  • hair tresses (8 hour bleached) were washed as above using Formulation A, Formulation B or Comparative 1 and dried.
  • Very damaged hair e.g., 8-hour bleached hair
  • Hydrophobicity can be used as a measure of repair by replacing the fatty acid coating and indicates deposition of a substance on the hair during shampooing.
  • Formulation A and Formulation B have a hydrophobicity (determined by advancing contact angle) of 55.8 + 11.5, 85.3 + 0.85, respectively, compared to 45.2 + 4.40 for untreated 8 hour bleached hair. Comparative 1 did not increase hydrophobicity, thus, it is believed that the mechanism for hair conditioning of the cationic polymer is different from that of the inventive formulations.
  • Exemplary personal care rinse-off conditioning compositions contain the components weight/weight basis (wt. %) recited in TABLE 4.
  • Phase A ingredients Combine Phase A ingredients, mix, and heat to 75°C under stirring.
  • phase B ingredients are combined, mixed and heated to 75°C under stirring
  • Phase B is added to phase A at 75°C under stirring at 470 rpm.
  • the reaction mixture is allowed to cool to room temperature while stirring.
  • Glydant is added at 35 °C.
  • Batch A is added to the mixture at room temperature and mixed in for 20 min. pH of the formulation was adjusted to 4 - 5 using 50% citric acid as needed.
  • Comparative personal care rinse-off conditioning compositions contain the components weight/weight basis (wt. %) recited in TABLE 5.
  • compositions are prepared as in Example 5, except that Batch A is not present and Glydant and DC 345 are added at 35 °C.
  • Compositions substantially according to the protocols of Examples 5 and 6 were prepared. Pre- washed and pre-hydrated ten inch long hair tresses of European single- bleached hair (available from International Hair Importers and Products Inc. (Floral Park, NY)) were treated with 0.1 g of the conditioner formulations, which was worked into the hair for 1 min. and then rinsed off under running tap water at 38°C and 0.4 gal./min. water flow.
  • the hair tresses were hung for wet sensory evaluation study. After the tresses were completely dried, dry sensory evaluations were conducted. Ten expert panelists trained to evaluate the performance of cosmetic products on hair were asked to evaluate comb-ability and feel in both the wet and dry stage. Each panelist evaluated a pair of tresses, one tress treated with Formulation C of the present invention versus one treated with a Comparative 4 composition. The panelists were asked to pick one tress that combed easier and felt more slippery/smoother (wet) or silkier/softer (dry). The inventive formulation was found similar to the comparative formulation in all categories tested (differences not statistically significant on wet and dry hair), showing the inventive formulation displayed similar performance to silicones.
  • Exemplary personal care leave-on conditioner compositions contain the components recited in TABLE 6 on a weight/weight basis (wt. %).
  • CELLOSIZE PCG-10 is sprinkled into rapidly agitating, room temperature water. Once uniform, the solution is heated to 60 °C and cetrimonium chloride is added to the mixture and stirred until dissolved. The pre-mix is then heated to 75°C under stirring. In a separate reaction vessel, fatty alcohols of phase B are combined, mixed until uniform and heated to 75°C under stirring. Vegetable oil is added in under stirring. Phase B is added to phase A at 75°C under stirring at 470 rpm. The reaction mixture is allowed to cool while stirring. Phase C ingredients are added at 35 °C, and pH of the formulation was adjusted to 4 - 5 using 50% citric acid as needed.
  • Exemplary personal care shampoo compositions contain the components recited in TABLE 7 on a weight/weight basis (wt. %).
  • Conventional personal care shampoo compositions contain the components recited in TABLE 8 on a weight/weight basis (wt. %).
  • Control shampoo is prepared substantially as described in Example 9, but contains commercial ZPT dispersion available from Arch Chemical as ZINC OMADINE FPS dispersion.
  • compositions substantially according to the protocols of Examples 9 and 10 were prepared and applied to virgin brown hair.
  • the tresses were tested substantially according to the methods described in Example 4, and Formulation F deposits at least 25% more zinc onto hair than the Comparative 5 composition (17.1 ppm vs. 13.6 ppm).
  • Exemplary personal care shampoo compositions contain the components recited in TABLE 9 on a weight/weight basis (wt. %).
  • Conventional personal care shampoo compositions contain the components recited in TABLE 10 on a weight/weight basis (wt. %).
  • compositions substantially according to the protocols of Examples 11 and 12 were prepared. Pre- washed and pre-hydrated ten inch long hair tresses of European Virgin Brown and 8-hour bleached hair (available from International Hair Importers and Products Inc. (Floral Park, NY)) were treated with 0.5 g of the formulations, which was worked into the hair for 1 min. and then rinsed off under running tap water at 38°C and 0.4 gal./min. water flow.
  • One group of the hair tresses were dried in an oven at 38°C. After the tresses were completely dried, they were curled using a curling iron for one minute. The curls were released and photographs of the curled tresses were taken for evaluation.
  • Another group of the hair tresses were roller curled by diagonally applying wet hair onto a 65mm x 20mm curler, held in place with two large bobby pins. These were air dried at ambient temperatures for 3 days, then placed in a 45°C oven for one hour to ensure they were thoroughly dried. Curlers were then removed and the curled hair tresses were placed in a high humidity chamber (25°C, 90% relative humidity) for 24 hours. The curled tresses were removed from the humidity chamber and photographs of the curled tresses were taken for evaluation.
  • each recited range includes all combinations and subcombinations of ranges, as well as specific numerals contained therein. Additionally, the disclosures of each patent, patent application, and publication cited or described in this document are hereby incorporated herein by reference, in their entireties.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)

Abstract

L'invention porte sur des compositions de soin personnel qui comportent une dispersion aqueuse comportant un copolymère éthylène-acide acrylique et au moins un agent tensioactif de qualité cosmétique, un émollient ou un actif cosmétique.
EP10755297.8A 2009-09-15 2010-09-15 Compositions de soin personnel avec des dispersions aqueuses de copolymère éthylène-acide acrylique Active EP2477601B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24249009P 2009-09-15 2009-09-15
US35337210P 2010-06-10 2010-06-10
PCT/US2010/048868 WO2011034883A2 (fr) 2009-09-15 2010-09-15 Compositions de soin personnel avec des dispersions aqueuses de copolymère éthylène-acide acrylique

Publications (2)

Publication Number Publication Date
EP2477601A2 true EP2477601A2 (fr) 2012-07-25
EP2477601B1 EP2477601B1 (fr) 2017-09-13

Family

ID=43730782

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10755297.8A Active EP2477601B1 (fr) 2009-09-15 2010-09-15 Compositions de soin personnel avec des dispersions aqueuses de copolymère éthylène-acide acrylique

Country Status (6)

Country Link
US (1) US8771657B2 (fr)
EP (1) EP2477601B1 (fr)
JP (1) JP5937512B2 (fr)
CN (1) CN102791251B (fr)
BR (1) BR112012005680B1 (fr)
WO (1) WO2011034883A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011034877A2 (fr) * 2009-09-15 2011-03-24 Dow Global Technologies Inc. Auxiliaire de dépôt de silicone pour compositions de soins d'hygiène et de beauté
WO2011156579A2 (fr) * 2010-06-10 2011-12-15 Union Carbide Chemicals & Plastics Technology Llc Compositions de soins personnels contenant des dispersions aqueuses de copolymère d'acrylate/éthylène
EP2629743B1 (fr) * 2010-10-20 2015-06-10 Union Carbide Chemicals & Plastics Technology LLC Produits fixateurs pour les cheveux
WO2012082624A2 (fr) * 2010-12-17 2012-06-21 Dow Global Technologies Llc Dispersions aqueuses de copolymères d'éthylène et d'acide acrylique utilisables en vue de la libération d'un parfum dans les lessives
CN103608447B (zh) * 2011-06-17 2015-10-07 陶氏环球技术有限责任公司 织物护理粒料和方法
US9872820B2 (en) 2012-09-24 2018-01-23 Dow Global Technologies Llc Personal care sensory agents
WO2014058670A1 (fr) * 2012-10-11 2014-04-17 Dow Global Technologies Llc Dérivés de cellulose sans glyoxal pour des compositions de soins personnels
MX2016003236A (es) 2013-09-27 2016-06-07 Rohm & Haas Peliculas dispersables para envasar formulaciones de alto contenido de agua.
CN105592843B (zh) * 2013-09-27 2021-09-14 罗门哈斯公司 包含漂白剂的口腔护理组成物
WO2015081006A1 (fr) 2013-11-27 2015-06-04 Rohm And Haas Chemicals Llc Films et particules dispersibles dans l'eau pour libération déclenchée d'enzymes
EP3116468B1 (fr) * 2014-03-10 2018-11-14 Dow Global Technologies LLC Agents sensoriels de soins capillaires
CN108289798A (zh) * 2015-12-11 2018-07-17 罗门哈斯公司 浓缩聚烯烃乳液和含有其的护发组合物
CN108307621A (zh) * 2015-12-11 2018-07-20 罗门哈斯公司 浓缩聚烯烃乳液和含有其的个人护理组合物
EP3423518B1 (fr) 2016-03-01 2020-03-25 Dow Global Technologies LLC Films polymères et emballages de détergent les contenant
US11369561B2 (en) * 2018-01-22 2022-06-28 Henkel Ag & Co. Kgaa Compositions and methods for hair coloring
WO2019142169A1 (fr) 2018-01-22 2019-07-25 Landa Labs (2012) Ltd. Procédés de coloration de textile
WO2019240968A1 (fr) * 2018-06-11 2019-12-19 Dow Global Technologies Llc Composition de pain de savon d'hygiène personnelle

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599392A (en) 1983-06-13 1986-07-08 The Dow Chemical Company Interpolymers of ethylene and unsaturated carboxylic acids
ZA861309B (en) * 1985-02-28 1986-10-29 Procter & Gamble Sunscreen compositions
US4701432A (en) 1985-11-15 1987-10-20 Exxon Chemical Patents Inc. Supported polymerization catalyst
US4988781A (en) 1989-02-27 1991-01-29 The Dow Chemical Company Process for producing homogeneous modified copolymers of ethylene/alpha-olefin carboxylic acids or esters
ATE176396T1 (de) * 1987-10-22 1999-02-15 Procter & Gamble Chelatbildner enthaltende lichtschutzmittel
ES2148147T3 (es) 1989-02-27 2000-10-16 Dow Chemical Co Procedimiento para producir copolimeros modificados homogeneos de etileno/acidos carboxilicos de alfa-olefinas o sus esteres.
US5272236A (en) 1991-10-15 1993-12-21 The Dow Chemical Company Elastic substantially linear olefin polymers
US5322728A (en) 1992-11-24 1994-06-21 Exxon Chemical Patents, Inc. Fibers of polyolefin polymers
US5935561A (en) 1996-03-27 1999-08-10 Procter & Gamble Company Conditioning shampoo compositions containing select hair conditioning agents
AU709582B2 (en) 1996-03-27 1999-09-02 Procter & Gamble Company, The Conditioning shampoo compositions containing polyalphaolefin conditioner
US6221817B1 (en) 1996-03-27 2001-04-24 The Procter & Gamble Company Conditioning shampoo composition
US6525157B2 (en) 1997-08-12 2003-02-25 Exxonmobile Chemical Patents Inc. Propylene ethylene polymers
US5938437A (en) 1998-04-02 1999-08-17 Devincenzo; John Bony anchor positioner
US7074388B2 (en) 1998-12-10 2006-07-11 Kos Life Science, Inc. Water stabilized medicinal aerosol formulation
US6696067B2 (en) 2001-04-12 2004-02-24 Ondeo Nalco Company Cosmetic compositions containing dispersion polymers
CN1655753A (zh) 2001-10-03 2005-08-17 宝洁公司 包含颗粒和沉积助剂的洗发剂
US6960635B2 (en) 2001-11-06 2005-11-01 Dow Global Technologies Inc. Isotactic propylene copolymers, their preparation and use
WO2003082232A1 (fr) * 2002-03-28 2003-10-09 The Procter & Gamble Company Compositions de stabilisation de particules
ATE468887T1 (de) 2002-06-04 2010-06-15 Procter & Gamble Haarwaschmittel enthaltend ein gelförmiges system
US7829069B2 (en) * 2002-10-15 2010-11-09 Yoram Fishman Hair treatment systems and methods
US7314904B2 (en) 2003-06-18 2008-01-01 Baker Hughes Incorporated Functionalized polyalphaolefins
US20060127345A1 (en) 2004-12-10 2006-06-15 Hilvert Jennifer E Conditioning shampoo containing stabilized silicone particles
DE102005049261B3 (de) * 2005-10-14 2007-03-29 Siemens Ag Kühlerlüfter für ein Kraftfahrzeug
US8043713B2 (en) * 2005-12-15 2011-10-25 Dow Global Technologies Llc Compositions and aqueous dispersions
US7803250B2 (en) * 2005-12-15 2010-09-28 Dow Global Technologies, Inc. Wiping products having enhanced cleaning abilities
US20080020057A1 (en) 2006-07-18 2008-01-24 Michael Frederick Niebauer Personal care composition containing microemulsified wax particles
US7823097B2 (en) 2006-09-15 2010-10-26 International Business Machines Corporation Unrolling hardware design generate statements in a source window debugger
AU2007330430B2 (en) * 2006-12-07 2011-04-14 Kimberly-Clark Worldwide, Inc. Tissue products with controlled lint properties
JP5203622B2 (ja) * 2007-03-30 2013-06-05 株式会社コーセー 油性化粧料
JP2008247833A (ja) * 2007-03-30 2008-10-16 Kose Corp 乳化化粧料
JP2009029718A (ja) * 2007-07-24 2009-02-12 Kose Corp 化粧料
AU2008321129B2 (en) * 2007-11-16 2013-10-10 Dow Global Technologies Llc Encapsulated low viscosity hydrophobic liquid actives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2011034883A2 *

Also Published As

Publication number Publication date
CN102791251A (zh) 2012-11-21
US8771657B2 (en) 2014-07-08
US20110064683A1 (en) 2011-03-17
BR112012005680B1 (pt) 2017-10-31
EP2477601B1 (fr) 2017-09-13
JP5937512B2 (ja) 2016-06-22
WO2011034883A3 (fr) 2012-08-23
WO2011034883A2 (fr) 2011-03-24
BR112012005680A2 (pt) 2016-02-23
JP2013504629A (ja) 2013-02-07
CN102791251B (zh) 2015-07-01

Similar Documents

Publication Publication Date Title
US8771657B2 (en) Personal care compositions with ethylene acrylic acid copolymer aqueous dispersions
EP2477599B1 (fr) Auxiliaire de dépôt de silicone pour compositions de soins d'hygiène et de beauté
US20110305653A1 (en) Personal care compositions with ethylene acrylic acid copolymer aqueous dispersions
EP2914239A1 (fr) Composition comprenant un polymère de conditionnement et/ou de coiffage
EP3197937B1 (fr) Composés de silicone et compositions les contenant pour le traitement de substrats à base d'acides aminés
EP2170247A2 (fr) Films solubles de soins d'hygiène personnelle
EP3137039A1 (fr) Composition d'hygiène personnelle pour un substrat de kératine comprenant un polymère d'après-shampooing et/ou de coiffage
US8715630B2 (en) Silicone replacements for personal care compositions
CA2939126C (fr) Compositions aqueuses de coiffage comprenant deux copolymeres d'acrylate/silicone
WO2023148138A1 (fr) Composés destinés à être utilisés en tant qu'agents de réparation capillaire ou agents de réparation de tissu
JP2013514360A (ja) 3級アミノ変性セルロース誘導体を有するパーソナルケア組成物
US10123961B2 (en) Personal care compositions with modified guar derivatives

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME RS

R17D Deferred search report published (corrected)

Effective date: 20120823

RIC1 Information provided on ipc code assigned before grant

Ipc: A61Q 5/12 20060101ALI20120905BHEP

Ipc: A61K 8/81 20060101AFI20120905BHEP

17P Request for examination filed

Effective date: 20130225

RBV Designated contracting states (corrected)

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20131115

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20170421

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 8

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: MURGITROYD AND COMPANY, CH

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 927469

Country of ref document: AT

Kind code of ref document: T

Effective date: 20171015

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602010045223

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20170913

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171213

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 927469

Country of ref document: AT

Kind code of ref document: T

Effective date: 20170913

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171213

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171214

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180113

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602010045223

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20170930

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170915

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170915

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

26N No opposition filed

Effective date: 20180614

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170930

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170915

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20100915

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170913

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20190913

Year of fee payment: 10

REG Reference to a national code

Ref country code: DE

Ref legal event code: R081

Ref document number: 602010045223

Country of ref document: DE

Owner name: UNION CARBIDE CORPORATION, SEADRIFT, US

Free format text: FORMER OWNER: UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY LLC, MIDLAND, MICH., US

Ref country code: DE

Ref legal event code: R082

Ref document number: 602010045223

Country of ref document: DE

Representative=s name: MURGITROYD & COMPANY, DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

Free format text: REGISTERED BETWEEN 20200305 AND 20200311

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170913

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200930

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200930

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230525

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20230727

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20230710

Year of fee payment: 14

Ref country code: DE

Payment date: 20230718

Year of fee payment: 14